Health services use by children identified as heterozygous hemoglobinopathy mutation carriers via newborn screening

BACKGROUND: Newborn screening (NBS) for sickle cell disease incidentally identifies heterozygous carriers of hemoglobinopathy mutations. In Ontario, Canada, these carrier results are not routinely disclosed, presenting an opportunity to investigate the potential health implications of carrier status...

Descripción completa

Detalles Bibliográficos
Autores principales: Khangura, Sara D., Potter, Beth K., Davies, Christine, Ducharme, Robin, Bota, A. Brianne, Hawken, Steven, Wilson, Kumanan, Karaceper, Maria D., Klaassen, Robert J., Little, Julian, Simpson, Ewurabena, Chakraborty, Pranesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247172/
https://www.ncbi.nlm.nih.gov/pubmed/34210267
http://dx.doi.org/10.1186/s12887-021-02751-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247172/
https://www.ncbi.nlm.nih.gov/pubmed/34210267
http://dx.doi.org/10.1186/s12887-021-02751-8

Ejemplares similares